CIK 0001501989 · Accelerated filer
CytomX Therapeutics, Inc.
Sign in to watch- Ticker
- CTMX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 273521219
- Phone
- 650.515.3185
- Business address
- 151 OYSTER POINT BLVD., SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-07-19 | ROWLAND LLOYD A General Counsel | Grant or award | +15,000 | 49,291 | ||
| 2022-07-19 | HANNAH ALISON L. Chief Medical Officer | Grant or award | +15,000 | 37,500 | ||
| 2022-07-19 | Campoy Carlos Chief Financial Officer | Grant or award | +15,000 | 43,921 | ||
| 2022-06-15 | Young Matthew P. Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2022-06-15 | Mohindru Mani Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2022-06-15 | Meyers James R Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2022-06-15 | Gilbert Halley E Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2022-06-15 | GLUCK FREDERICK W Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2022-06-15 | Jones Elaine V Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2022-06-15 | Ashworth Alan Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2022-05-09 | McCarthy Sean A. President and CEO | Option exercise | +66,742 | $0.95 | $63K | 241,664 |
| 2022-05-09 | McCarthy Sean A. President and CEO | Option exercise | +24,189 | $0.95 | $23K | 265,853 |
| 2022-05-09 | McCarthy Sean A. President and CEO | Option exercise · Stock Option (Right to Buy) | −66,742 | 0 | ||
| 2022-05-09 | McCarthy Sean A. President and CEO | Option exercise · Stock Option (Right to Buy) | −24,189 | 0 | ||
| 2022-02-02 | Peterson Amy C. EVP, Chief Development Officer | Grant or award | +40,000 | 46,421 | ||
| 2022-02-02 | Peterson Amy C. EVP, Chief Development Officer | Grant or award · Stock Option (Right to Buy) | +200,000 | 200,000 | ||
| 2022-02-02 | ROWLAND LLOYD A General Counsel | Grant or award | +22,500 | 34,291 | ||
| 2022-02-02 | ROWLAND LLOYD A General Counsel | Grant or award · Stock Option (Right to Buy) | +135,000 | 135,000 | ||
| 2022-02-02 | HANNAH ALISON L. Chief Medical Officer | Grant or award | +22,500 | 22,500 | ||
| 2022-02-02 | HANNAH ALISON L. Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +135,000 | 135,000 |
Page 11 of 33 · 649 trades